As biosimilars struggle to live up to their promise of cutting costs and improving access to biologic medicines for U.S.

Southwest Airlines is buckling up to join in on a long-running legal battle surrounding an alleged price-fixing scheme ...

Achieve Life Sciences has signed up Omnicom to support the launch of nicotine dependence treatment cytisinicline, positioning ...

The pharma began its outreach to the HS community well before securing Bimzelx’s approval in the indication. In the spring of ...

Novartis and a Swiss nonprofit have made history, scoring the world’s first approval for a medicine to treat babies who are ...

While only 10% to 15% of those who are diagnosed with NSCLC in the U.S. have EGFR mutations, the approval represents a key entry into the cancer type as the companies await results from a trial ...

Amarin’s sales of Vascepa have plummeted since it caved to generic competition in the U.S. in 2020, just three months after the FDA granted it what seemed to be a game-changing label expansion ...

In a phase 3 trial, Andembry significantly reduced investigator-confirmed HAE attacks per month versus placebo, according to results published in The Lancet in April of 2023. Of the 39 patients ...

AstraZeneca penned a discovery pact with China's CSPC Pharma. The FDA halted new trials that export American people's living cells to China.

The bipartisan Orphan Cures Act would allow drugs with multiple rare disease indications to be exempt from Medicare’s drug price negotiations under the IRA. As it stands, the IRA applies such ...

MilliporeSigma and Simtra BioPharma Solutions have forged a partnership, creating a “turnkey offering” for drugmakers seeking ADC manufacturing.